The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
Bisphosphonates are well established in the management of breast-cancer-induced bone disease. Recent studies have suggested that these compounds are effective in preventing the development of bone metastases. However, it is unclear whether this reflects an indirect effect via an inhibition of bone r...
Үндсэн зохиолчид: | Jagdev, S, Coleman, R, Shipman, C, Rostami-H, A, Croucher, P |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2001
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
-н: Allan Lipton
Хэвлэсэн: (2011-03-01) -
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.
-н: Shipman, C, зэрэг
Хэвлэсэн: (1997) -
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
-н: Luca Dalle Carbonare, зэрэг
Хэвлэсэн: (2010-08-01) -
Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
-н: Xin Chen, зэрэг
Хэвлэсэн: (2021-11-01) -
Bisphosphonates and in vivo models of multiple myeloma - Reply
-н: Shipman, C, зэрэг
Хэвлэсэн: (2001)